Total Valuation
Health Advance has a market cap or net worth of $194.83K. The enterprise value is $356.36K.
Market Cap$194.83K
Enterprise Value$356.36K
Share Statistics
Health Advance has 974,136,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding974,136,400
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Health Advance’s return on equity (ROE) is 0.48 and return on invested capital (ROIC) is -37.62%.
Return on Equity (ROE)0.48
Return on Assets (ROA)-0.17
Return on Invested Capital (ROIC)-37.62%
Return on Capital Employed (ROCE)-0.70
Revenue Per Employee0.00
Profits Per Employee-29.07K
Employee Count3
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Health Advance is 2.0. Health Advance’s PEG ratio is 0.00.
PE Ratio2.0
PS Ratio0.00
PB Ratio-2.29
Price to Fair Value-2.29
Price to FCF-7.50
Price to Operating Cash Flow-4.54
PEG Ratio0.00
Income Statement
In the last 12 months, Health Advance had revenue of 0.00 and earned -87.21K in profits. Earnings per share was <0.01.
Revenue0.00
Gross Profit0.00
Operating Income-65.41K
Pretax Income-87.21K
Net Income-87.21K
EBITDA-65.41K
Earnings Per Share (EPS)<0.01
Cash Flow
In the last 12 months, operating cash flow was -56.19K and capital expenditures -5.00, giving a free cash flow of -56.20K billion.
Operating Cash Flow-56.19K
Free Cash Flow-56.20K
Free Cash Flow per Share>-0.01
Dividends & Yields
Health Advance pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.37
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Health Advance upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Health Advance as a current ratio of 0.79, with Debt / Equity ratio of -194.72%
Current Ratio0.79
Quick Ratio0.79
Debt to Market Cap0.85
Net Debt to EBITDA-5.44
Interest Coverage Ratio-2.71
Taxes
In the past 12 months, Health Advance has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Health Advance EV to EBITDA ratio is -11.89, with an EV/FCF ratio of -13.84.
EV to Sales0.00
EV to EBITDA-11.89
EV to Free Cash Flow-13.84
EV to Operating Cash Flow-13.84
Balance Sheet
Health Advance has $1.28K in cash and marketable securities with $357.45K in debt, giving a net cash position of -$356.17K billion.
Cash & Marketable Securities$1.28K
Total Debt$357.45K
Net Cash-$356.17K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Health Advance is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast50.00%